Evidence map›Paper›PMID 28529534›Full record

ArticleNutrition & metabolism2017

The role of a dairy fraction rich in milk fat globule membrane in the suppression of postprandial inflammatory markers and bone turnover in obese and overweight adults: an exploratory study.

Tara S Rogers, Elieke Demmer, Nancy Rivera, Erik R Gertz, J Bruce German, Jennifer T Smilowitz, Angela M Zivkovic, Marta D Van Loan

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrition & metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01811329 (Effects of Dairy Fat on Postprandial Inflammation- Phase 1), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01811329 naactive not recruitingnot on this map

Effects of Dairy Fat on Postprandial Inflammation- Phase 1

TypeinterventionalSponsorUniversity of California, DavisRan2013 to 2027Enrolled38ConditionsMetabolic Syndrome, ObesityArmsDairy fat, Dairy fat + MFGM, Palm fat, Palm fat + MFGM
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Reduced postprandial bone resorption and greater rise in GLP-1 in overweight and obese individuals after an α-glucosidase inhibitor: a double-blinded randomized crossover trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Trial
  2. Trial
  3. Article
  4. Milk phospholipids protectFrontiers in nutrition · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tara S RogersDepartment of Nutrition, University of California, Davis, 1 Shields Avenue, Davis, CA 95616 USA.
Elieke DemmerDepartment of Nutrition, University of California, Davis, 1 Shields Avenue, Davis, CA 95616 USA.
Nancy RiveraDepartment of Nutrition, University of California, Davis, 1 Shields Avenue, Davis, CA 95616 USA.
Erik R GertzUSDA, Agricultural Research Service, Western Human Nutrition Research Center, 430 West Health Sciences Drive, Davis, CA 95616 USA.
J Bruce GermanFoods for Health Institute, University of California, Davis, 1 Shields Avenue, Davis, CA 95616 USA.
Jennifer T SmilowitzFoods for Health Institute, University of California, Davis, 1 Shields Avenue, Davis, CA 95616 USA.
Angela M ZivkovicDepartment of Nutrition, University of California, Davis, 1 Shields Avenue, Davis, CA 95616 USA.
Marta D Van LoanDepartment of Nutrition, University of California, Davis, 1 Shields Avenue, Davis, CA 95616 USA.
University of California, Davis · USWestern Human Nutrition Research Center · USWest Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInflammation is associated with increased bone resorption; the role of inflammation in postprandial bone turnover has not been explored. Consumption of milk fat globule membrane (MFGM) reduces inflammation in animal models. This study aimed to measure postprandial changes in bone turnover after intake of high saturated fat test meals, with- and without the anti-inflammatory ingredient MFGM.

methodsSubjects (

resultsTest meal (treatment) by time interactions were significant for bone resorption marker C-telopeptide of type 1 collagen (CTX) (

conclusionThis exploratory analysis advances the study of postprandial suppression of bone turnover by demonstrating differing effects of high SFA meals that contained MFGM; however MFGM alone did not directly moderate the difference in postprandial CTX response among test meals in this analysis. These observations may be useful for identifying foods and ingredients which maximize the suppression of bone resorption, and for generating hypotheses to test in future studies examining the role of inflammation in postprandial bone turnover.

trial registrationClinicaltrials.gov NCT01811329. Registered 11 March 2013.

Indexed as

Bone TurnoverC-telopeptide of type 1 collagen (CTX)InflammationMilk Fat Globule MembranePostprandial

Identifiers

PMID28529534
PMCPMC5436451
OpenAlexW2616040188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.